Our purpose
Ketamine treatment sits in an unusual gap: real science, rapid growth, and, because most of it is off-label, almost no standardized consumer protection. The result is an industry where a person researching help for serious depression encounters more marketing than evidence. KetamineTreatmentGuide.com gives that person plain-language, sourced information that no clinic or provider pays to shape.
Who publishes this site
Ketamine Treatment Guide is published by ZSKFL Management, which writes and edits every guide and article. Our pages are not reviewed by a clinician. Each one is checked against its listed sources and shows the date it was last updated.
Editorial standards
- Evidence first. We distinguish clearly between FDA-approved uses, well-studied off-label uses, and experimental applications, and we say so when evidence is thin.
- Primary sources. Our clinical and regulatory claims trace to FDA documents, peer-reviewed research, and official health agencies. Where no public data exist, such as cash-pay clinic prices, we say so and name the commercial source.
- Plain language. No jargon without explanation, no euphemism about risks or costs.
- Crisis resources always visible. Every page of this site carries crisis contact information, because some of our readers need it more than they need us.
How this site is funded
Ketamine Treatment Guide is an educational resource, not a treatment provider. The owner of this site also has an ownership interest in a behavioral health treatment provider. We are disclosing that connection so you can weigh it. This site does not refer readers to that provider or any other, is not paid for referrals, and does not share what you send through our form with any provider. No provider can pay to change our guides, evidence rankings, or clinic-evaluation criteria. If that ever changes, we will say so on the pages affected. We do not sell personal information. See our Privacy Policy.
Medical disclaimer
KetamineTreatmentGuide.com provides general educational information only. Nothing on this site constitutes medical advice, diagnosis, or treatment, and it is not a substitute for care from a licensed clinician who knows your history. Ketamine for psychiatric conditions, other than esketamine (Spravato®) for its FDA-approved indications, is an off-label use with real risks, and it is not appropriate for everyone. Always consult a qualified healthcare provider before making treatment decisions, and never disregard professional medical advice because of something you read here.
Corrections
If you believe something on this site is inaccurate or out of date, contact us. We review correction requests against primary sources and update pages accordingly.